FDA relaxes EUA advertising limitation for some COVID drugs

The US Food and Drug Administration (FDA) has relaxed a limitation on advertising and promotion for certain COVID-19 drugs with emergency use authorizations (EUAs). The agency said that “truthful and non-misleading” advertising and promotion of COVID-19 therapeutics could benefit the public health, though some caveats to how the drugs can be promoted still apply.